CDTX vs CUBE
Cidara Therapeutics Inc (CDTX) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
CDTX currently screens at market cap $6.96B. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the CDTX and CUBE stock pages for the full models.
Not investment advice.